Figure 4.
A novel strategy for cancer prevention. If the pathway(s) that underlie damage-induced mutagenesis can be inhibited by a therapeutic agent, significant decreases
in cancer risk can be expected (solid line). Decreasing mutation rates could also block or slow down tumor progression, achieving
cancer suppression (dashed line).